Literature DB >> 26700025

Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations.

Jacques Luauté1, David Plantier2, Laurent Wiart3, Laurence Tell4.   

Abstract

UNLABELLED: The agitation crisis in the awakening phase after traumatic brain injury (TBI) is one of the most difficult behavioral disorders to alleviate. Current treatment options are heterogeneous and may involve excessive sedation. Practice guidelines are required by professionals in charge of TBI patients. Few reviews were published but those are old and based on expert opinions. The purpose of this work is to propose evidence-based guidelines to treat the agitation crisis.
METHODS: The elaboration of these guidelines followed the procedure validated by the French health authority for good practice recommendations, close to the Prisma statement. Guidelines were elaborated on the basis of a systematic and critical review of the literature.
RESULTS: Twenty-eight articles concerning 376 patients were analyzed. Recommendations are: when faced with an agitation crisis, the management strategy implies to search for an underlying factor that should be treated such as pain, acute sepsis, and drug adverse effect (expert opinion). Physical restraints should be discarded when possible (expert opinion). Neuroleptic agent with a marketing authorization can be used in order to obtain a quick sedation so as to protect the patient from himself, closed ones or the healthcare team but the duration should be as short as possible (expert opinion). The efficacy of beta-blockers and antiepileptics with mood regulation effects like carbamazepine and valproate yield the most compelling evidence and should be preferably used when a background regimen is envisioned (grade B for beta-blocker and C for antiepileptics). Neuroleptics, antidepressants, benzodiazepines, buspirone may be prescribed but are considered second-line treatments (expert opinion).
CONCLUSION: This study provides a strategy for treating the agitation crisis based on scientific data and expert opinion. The level of evidence remains low and published data are often old. New studies are essential to validate results from previous studies and test new drugs and non-pharmaceutical therapies.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aggressive behaviour; Agitation crisis; Guideline; Traumatic brain injury; Treatment strategy

Mesh:

Substances:

Year:  2015        PMID: 26700025     DOI: 10.1016/j.rehab.2015.11.001

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  12 in total

1.  Predisposing factors, clinical assessment, management and outcomes of agitation in the trauma intensive care unit.

Authors:  Saeed Mahmood; Omaima Mahmood; Ayman El-Menyar; Mohammad Asim; Hassan Al-Thani
Journal:  World J Emerg Med       Date:  2018

2.  Factors Associated With Deep Sedation Practice in Mechanically Ventilated Patients: A Post hoc Analysis of a Cross-Sectional Survey Combined With a Questionnaire for Physicians on Sedation Practices.

Authors:  Penglin Ma; Tao Wang; Yichun Gong; Jingtao Liu; Wei Shi; Lin Zeng
Journal:  Front Med (Lausanne)       Date:  2022-06-09

Review 3.  Neuropsychiatric sequelae of stroke.

Authors:  José M Ferro; Lara Caeiro; Maria Luísa Figueira
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

Review 4.  Untangling PTSD and TBI: Challenges and Strategies in Clinical Care and Research.

Authors:  Rebecca C Hendrickson; Abigail G Schindler; Kathleen F Pagulayan
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-08       Impact factor: 5.081

5.  Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.

Authors:  David R Williamson; Anne Julie Frenette; Lisa Burry; Marc M Perreault; Emmanuel Charbonney; François Lamontagne; Marie-Julie Potvin; Jean-François Giguère; Sangeeta Mehta; Francis Bernard
Journal:  Syst Rev       Date:  2016-11-17

6.  Using propranolol in traumatic brain injury to reduce sympathetic storm phenomenon: A prospective randomized clinical trial.

Authors:  Mona Ahmed Ammar; Noha Sayed Hussein
Journal:  Saudi J Anaesth       Date:  2018 Oct-Dec

7.  The Efficacy and Harms of Pharmacological Interventions for Aggression After Traumatic Brain Injury-Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Malcolm Hopwood; Amelia C James; Mahesh Jayaram; Luke A Perry; Rachel Batty; Jennie L Ponsford
Journal:  Front Neurol       Date:  2019-11-29       Impact factor: 4.003

8.  Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling.

Authors:  Jianing Luo; Xun Wu; Haixiao Liu; Wenxing Cui; Wei Guo; Kang Guo; Hao Guo; Kai Tao; Fei Li; Yingwu Shi; Dayun Feng; Hao Yan; Guodong Gao; Yan Qu
Journal:  Neurosci Bull       Date:  2020-10-27       Impact factor: 5.203

9.  Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial.

Authors:  Ruby K Phyland; Adam McKay; John Olver; Mark Walterfang; Malcolm Hopwood; Amelia J Hicks; Duncan Mortimer; Jennie L Ponsford
Journal:  Trials       Date:  2020-07-20       Impact factor: 2.279

10.  Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial.

Authors:  Shoumitro Deb; Lina Aimola; Verity Leeson; Mayur Bodani; Lucia Li; Tim Weaver; David Sharp; Paul Bassett; Mike Crawford
Journal:  BMJ Open       Date:  2020-09-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.